A Phase 1a-b Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer

Trial Profile

A Phase 1a-b Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs BMX 001 (Primary) ; Cisplatin
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Acronyms BMX-HN
  • Sponsors BioMimetix
  • Most Recent Events

    • 18 Apr 2017 Planned End Date changed from 1 Jul 2019 to 1 Apr 2019.
    • 18 Apr 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.
    • 18 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top